Crescent Capital Consulting’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$84K Buy
6,169
+1,129
+22% +$15.1K 0.01% 245
2021
Q3
$69K Sell
5,040
-150
-3% -$2.13K 0.01% 267
2021
Q2
$74K Sell
5,190
-493
-9% -$7.13K 0.01% 244
2021
Q1
$79K Buy
5,683
+519
+10% +$8.46K 0.02% 249
2020
Q4
$95K Buy
+5,164
New +$84.2K 0.02% 206

Other funds holding VTRS

Crescent Capital Consulting's VTRS Position: Q4 2021 in Review

Crescent Capital Consulting increased its Viatris (VTRS) stake by 22% in Q4 2021, buying an estimated $15.1K and bringing the position to 6,169 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #245.

Crescent Capital Consulting first reported a position in VTRS in Q4 2020 and has held it in 5 quarters since. The position peaked at $95K in Q4 2020. 1,071 funds tracked by Wall St. Rank hold VTRS as of Q4 2021.

  • Crescent Capital Consulting held 6,169 shares of Viatris worth $84K as of Q4 2021.
  • Crescent Capital Consulting bought 1,129 Viatris shares in Q4 2021, an estimated $15.1K.
  • Viatris made up 0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #245 holding.
  • Crescent Capital Consulting first reported a position in Viatris in Q4 2020 and has held it in 5 quarters since.
  • Crescent Capital Consulting's Viatris position peaked at $95K in Q4 2020.
  • 1,071 funds tracked by Wall St. Rank held Viatris as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.